OncoSec Medical Inc (ONCSQ)

[Titan V]

There may be TNBC p1 data, or additional p2b data from the existing UCSF trial, or some TAP announcements, all of which I think will be immaterial to impact the share price. That 2017 licensing milestone, although it now says "evaluate" at the beginning, may result in a slight lift if it does happen and if the collaboration is with a big pharma. I don't think it will be a $ deal. Perhaps another drug supply agreement.

All eyes will be on registration trial interim data in late Q4 (assuming some sites have already begun recruitment) or Q1'18 IMO.